Medtronic, Inc. (Medtronic) is engaged in medical technology - alleviating pain, restoring health, and extending life for millions of people worldwide. As of April, 27, 2012, the Company functions in two operating segments that manufacture and sells device-based medical therapies. The Company's operating segments include Cardiac and Vascular Group, which consists of Cardiac Rhythm Disease Management (CRDM) and CardioVascular, and Restorative Therapies Group, which consists of Spinal, Neuromodulation, Diabetes and Surgical Technologies. Medtronic serves hospitals, physicians, clinicians, and patients in more than 120 countries worldwide. The Company's primary customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations.
|Headquarters||710 Medtronic Parkway|
MINNEAPOLIS, MN, United States 55432-5604
|Chairman of the Board, Chief Executive Officer||Omar Ishrak|
|Chief Financial Officer, Senior Vice President||Gary Ellis|
|Executive Vice President, Group President - Cardiac and Vascular Group||Michael Coyle|
|Executive Vice President and Group President - Restorative Therapies Group||Christopher O'Connell|
|Senior Vice President, Chief Scientific, Clinical and Regulatory Officer||Richard Kuntz|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
|Shares Out.||1.0B||Book Value||$18.38|
|Annual Dividend Rate||$1.04||Price/Sales (TTM)||3.2|
|Ex-Div Date||4/3/13||P/Cash Flow (TTM)||12.5x|
|Pay Date||4/26/13||Operating Margin||25.63%|
*GAAP = prior to non-GAAP analyst adjusted earnings.